Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ghezzi

Showing results (181-190 of 198) with videos related to

Pageof 20
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammationM Félétou, M Lonchampt, P Robineau, et al.
Biochimica Et Biophysica Acta|June 19, 1998
Mycobacterial Cpn10 promotes recognition of the mammalian homologue by a mycobacterium-specific antiserumM Minto, G Galli, E Gianazza, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 1998
Differential contribution of R and S isomers in ketoprofen anti-inflammatory activity: role of cytokine modulationP Ghezzi, G Melillo, C Meazza, et al.
Neuroimmunomodulation|July 3, 1998
Centrally mediated inhibition of local inflammation by ciliary neurotrophic factorC Meazza, A Di Marco, P Fruscella, et al.
Heart (British Cardiac Society)|May 16, 2006
Increased erythropoietin production after myocardial infarction in miceM Mengozzi, R Latini, M Salio, et al.
Cytokine|January 1, 1992
Inhibitory effect of recombinant intracellular interleukin 1 receptor antagonist on endothelial cell activationR Bertini, M Sironi, I Martin-Padura, et al.
Breast Cancer Research and Treatment|August 8, 1998
Epirubicin/vinorelbine as first line therapy in metastatic breast cancerE Baldini, C Tibaldi, F Chiavacci, et al.
Shock (Augusta, Ga.)|November 15, 1997
Tumor necrosis factor is a brain damaging cytokine in cerebral ischemiaM E Meistrell, G I Botchkina, H Wang, et al.
Blood|March 1, 1996
Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1F Benigni, G Fantuzzi, S Sacco, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1997
The costs of dialysis in ItalyG Piccoli, M Formica, G Mangiarotti, et al.
Pageof 20

Showing results (181-190 of 198) with videos related to

Sort By:
Pageof 20
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Effects of the bradykinin B2 receptor antagonist S 16118 (p-guanidobenzoyl-[Hyp3,Thi5,D-Tic7,Oic8]bradykinin) in different in vivo animal models of inflammationM Félétou, M Lonchampt, P Robineau, et al.
Biochimica Et Biophysica Acta|June 19, 1998
Mycobacterial Cpn10 promotes recognition of the mammalian homologue by a mycobacterium-specific antiserumM Minto, G Galli, E Gianazza, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 1998
Differential contribution of R and S isomers in ketoprofen anti-inflammatory activity: role of cytokine modulationP Ghezzi, G Melillo, C Meazza, et al.
Neuroimmunomodulation|July 3, 1998
Centrally mediated inhibition of local inflammation by ciliary neurotrophic factorC Meazza, A Di Marco, P Fruscella, et al.
Heart (British Cardiac Society)|May 16, 2006
Increased erythropoietin production after myocardial infarction in miceM Mengozzi, R Latini, M Salio, et al.
Cytokine|January 1, 1992
Inhibitory effect of recombinant intracellular interleukin 1 receptor antagonist on endothelial cell activationR Bertini, M Sironi, I Martin-Padura, et al.
Breast Cancer Research and Treatment|August 8, 1998
Epirubicin/vinorelbine as first line therapy in metastatic breast cancerE Baldini, C Tibaldi, F Chiavacci, et al.
Shock (Augusta, Ga.)|November 15, 1997
Tumor necrosis factor is a brain damaging cytokine in cerebral ischemiaM E Meistrell, G I Botchkina, H Wang, et al.
Blood|March 1, 1996
Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1F Benigni, G Fantuzzi, S Sacco, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1997
The costs of dialysis in ItalyG Piccoli, M Formica, G Mangiarotti, et al.
Pageof 20